StoxQuest Laboratories Limited
NSE: QUESTLAB · Unclassified
Ask the data
Instant answers about Quest Laboratories Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY24 | FY25 | FY26 | |
|---|---|---|---|
| Revenue | 82.6 | 103.9 | 111.8 |
| EBITDA | 15.6 | 16.0 | 18.2 |
| Operating margin | 18.8% | 15.4% | 16.3% |
| Interest | 0.8 | 0.9 | 1.9 |
| Depreciation | 0.6 | 0.6 | 0.8 |
| Profit before tax | 14.4 | 18.7 | 18.1 |
| Tax | 4.3 | 5.1 | 3.1 |
| Net profit | 10.1 | 13.6 | 15.0 |
| EPS ₹ | 9.11 | 8.28 | 9.16 |
| Operating cash flow | 11.4 | -23.5 | -10.7 |
| Capex | -0.9 | 3.5 | 5.2 |
| Dividend paid | 0.0 | 0.0 | 0.0 |
| Total assets | — | 121.7 | 111.2 |
| Equity | — | 81.8 | 96.8 |
Quarterly performance
last 4 quarters · ₹ crore| JUN '25 | SEP '25* | DEC '25 | MAR '26* | |
|---|---|---|---|---|
| Revenue | 23.2 | 25.6 | 30.6 | 32.4 |
| Operating profit | 3.8 | 3.4 | 6.9 | 4.1 |
| Operating margin | 16.4% | 13.2% | 22.6% | 12.8% |
| Other income | 1.9 | 1.4 | 0.6 | -1.3 |
| Interest | 0.6 | 0.6 | 0.5 | 0.2 |
| Depreciation | 0.2 | 0.2 | 0.2 | 0.2 |
| Profit before tax | 4.8 | 4.0 | 6.8 | 2.5 |
| Tax | 0.7 | 0.0 | 2.8 | -0.4 |
| Net profit | 4.1 | 4.0 | 4.0 | 2.9 |
| EPS ₹ | 2.50 | 2.46 | 2.46 | 1.74 |
Returns & margins
trailing-twelve-month, per quarter| MAR '26 | |
|---|---|
| ROE | 15.5% |
| ROCE | 19.1% |
| Net margin | 13.4% |
| EBITDA margin | 16.3% |
| Debt / equity | 0.08 |
| Interest coverage | 10.79 |
| Asset turnover | 1.01 |
Balance sheet
equity vs borrowings over time · ₹ crore| SEP '24 | MAR '25 | SEP '25 | MAR '26 | |
|---|---|---|---|---|
| Share capital | 16.4 | 16.4 | 16.4 | 16.4 |
| Other equity / reserves | 63.4 | 65.4 | 73.5 | 80.4 |
| Total equity | 79.8 | 81.8 | 89.9 | 96.8 |
| Borrowings | 9.9 | 30.2 | 32.8 | 7.9 |
| Current liabilities | 30.2 | 37.2 | 42.0 | 12.5 |
| Non-current liabilities | 2.8 | 2.7 | 2.4 | 1.8 |
| Total assets | 112.8 | 121.7 | 134.3 | 111.2 |
| Property, plant & equipment | 11.2 | 11.8 | 15.7 | 14.8 |
| Capital work-in-progress | — | 0.0 | 0.0 | 1.5 |
| Investments | 0.3 | 49.2 | 53.0 | 12.2 |
| Inventories | 26.6 | 21.4 | 29.7 | 38.6 |
| Receivables | 31.1 | 30.0 | 30.1 | 36.2 |
| Cash & equivalents | 0.1 | 0.1 | 0.2 | 0.1 |
Cash flow
annual · ₹ crore · line = free cash flow| FY24 | FY25 | FY26 | |
|---|---|---|---|
| Cash from operations | 11.4 | -23.5 | -10.7 |
| Cash from investing | 5.0 | -44.0 | 34.9 |
| Cash from financing | -2.0 | 67.4 | -24.2 |
| Capex | -0.9 | 3.5 | 5.2 |
| Free cash flow | 12.4 | -26.9 | -16.0 |
| Dividends paid | 0.0 | 0.0 | 0.0 |
Where the assets sit
Mar '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Quest Laboratories Limited | 139 | 84.80 | 9.3 | 1.44 | 15.5% |
StoxGud checklist: Neutral setup · 4/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Quest Laboratories Limited?
Quest Laboratories Limited (QUESTLAB) closed at ₹84.80 on NSE on 05 Nov 2026.
What is the market cap of Quest Laboratories Limited?
₹139 crore at the latest close.
What is the P/E ratio of Quest Laboratories Limited?
9.3, on trailing-twelve-month earnings from its filings.
How fast is Quest Laboratories Limited growing?
Not enough filed history yet to measure Quest Laboratories Limited's growth.
How profitable is Quest Laboratories Limited?
On a trailing-twelve-month basis return on equity is 15.5%, return on capital employed 19.1%, operating margin 16.3%, net margin 13.4%.
How much debt does Quest Laboratories Limited have?
Quest Laboratories Limited is lightly geared: debt to equity is 0.08 with borrowings of ₹8 cr against cash of ₹0 cr (balance sheet of 2026-03-31). Operating profit covers interest 10.8 times.
Financials parsed from Quest Laboratories Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Quarterly from JUN '25, annual from FY24, balance sheet from Sep '24. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.